PHAT Stock-Based Compensation
Phathom Pharmaceuticals Inc · Stock-Based Compensation
PHAT Stock-Based Compensation
Latest reported$27.15Mperiod ending
PHAT Stock-Based Comp ($0.00 → $27.15M)
Annual stock-based compensation
High-resolution chart · PNG
PHAT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 28,719,000 | |
| 24,047,000 | |
| 45,025,000 | |
| 24,133,000 | |
| 16,812,000 | |
| 5,840,000 | |
| 406,000 | |
| 0 |